Skip to main content

The Wistar Institute

|

Daniel Claiborne, Ph.D.

Assistant Professor, Vaccine & Immunotherapy Center Genome Regulation and Cell Signaling Program, Ellen and Ronald Caplan Cancer Center Scientific Director, Histotechnology Facility
Read more
|

Wistar’s Medicinal Chemist Dr. Joe Salvino and the Journey to Drug Discovery

Joseph Salvino, Ph.D., medicinal chemist and professor in the Molecular & Cellular Oncogenesis Program and scientific director of the Molecular Screening & Protein Expression facility at The Wistar Institute, spent more than 20 years in the…
Read more
|

Wistar Researchers Discover Potential Target for Gastric Cancers Associated with Epstein-Barr Virus

PHILADELPHIA—(August 22, 2023)—Now, scientists at The Wistar Institute have discovered a potential target for gastric cancers associated with Epstein-Barr Virus; study results were published in the journal mBio. In the paper, Wistar’s Tempera lab in…
Read more
|

Women & Science: Helen Dean King Award Ceremony

Special Event Thursday, Nov. 16, 2023 6:00 p.m. to 8:00 p.m. Genes, the environment, and behavior: how simple animals teach us general lessons Cori Bargmann, Ph.D., past recipient of the prestigious Kavli Prize and the Breakthrough Prize in Life Sci…
Read more
|

The Wistar Institute Recruits Virology Expert Alexander Price, Ph.D., to Cancer Center

PHILADELPHIA—(August 9, 2023)— The Wistar Institute, an international biomedical research leader in cancer, immunology and infectious diseases, is pleased to announce the appointment of Alexander Price, Ph.D., as assistant professor in the Gene Expr…
Read more
|

The Wistar Institute Appoints Life Sciences Consultant and Entrepreneur Joy Taylor to its Board of Trustees

Philadelphia – (August 8, 2023) – The Wistar Institute, a global leader in biomedical research in cancer, immunology and infectious disease, is pleased to welcome Joy Taylor to its Board of Trustees. Taylor is CEO of EastEdge Consulting…
Read more
|

Wistar-Led Team Awarded More Than $12 Million Grant from the NCI to Investigate Link Between Epstein-Barr Virus and Carcinomas

PHILADELPHIA — (JULY 26, 2023) — It’s been known since the 1960s that Epstein-Barr Virus (EBV) causes a variety of cancers, but research has overwhelmingly focused on its connection to lymphomas. Now, a multidisciplinary team of scientists led by Th…
Read more
|

Wistar Scientists Collaborate with University of Buea Researchers to Identify Plant-Based Medicinal Compounds

Advanced computer models from Cameroon allow scientists to screen hundreds of compounds efficiently. Wistar Research Assistant Professor Dr. Ian Tietjen of the Montaner Lab — in his collaboration with Dr. Fidele Ntie-Kang, Associate Professor and He…
Read more
|

New Community Partnership Model Boosts Inclusion of Participants into HIV Cure-Directed Research 

PHILADELPHIA — (July 19, 2023) — Scientists have long used community advisory boards to engage communities and provide feedback on studies, but this model has limitations. Now, researchers from The Wistar Institute are sharing how a more inclusive m…
Read more
|

CBS3 Spotlights Wistar High School Training of Next-gen Scientists

Emmy-award winning CBS3 health reporter Stephanie Stahl stops by The Wistar Institute to meet the students and scientist-mentors behind this inclusive, essential training of the next generation of scientists.
Read more